Document is current
Any future updates will be listed below
-
Authors
Shimohata, Homare https://orcid.org/0000-0002-9648-5908
Usui, Joichi
Tawara-Iida, Takashi
Ebihara, Itaru
Ishizu, Takashi
Maeda, Yoshitaka
Kobayashi, Hiroaki
Numajiri, Daichi
Kaneshige, Ayaka
Sega, Masatoshi
Yamashita, Marina
Ohgi, Kentaro
Maruyama, Hiroshi
Takayasu, Mamiko
Hirayama, Kouichi
Kobayashi, Masaki
Yamagata, Kunihiro
,
-
Clinical Trials BETA
Clinical trials referenced in this document:
umin000010806 at UMIN JapanDocuments that mention this clinical trial
NT-pro BNP level at dialysis initiation is a useful biomarker for predicting hospitalization for ischemic heart disease
https://doi.org/10.1007/s10157-023-02442-x
- License Information
-
More Information
Article History
Received: 8 August 2023
Accepted: 28 November 2023
First Online: 19 January 2024
Declarations
:
: The authors have declared that no conflicts of interest exist.
: All procedures performed in the studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee at the institutions where the studies were conducted (IRB approval number IB1308) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.
: Refer to the original paper [].
